EP2968573A1 - Farbstofffreie flüssige therapeutische lösung - Google Patents

Farbstofffreie flüssige therapeutische lösung

Info

Publication number
EP2968573A1
EP2968573A1 EP14714047.9A EP14714047A EP2968573A1 EP 2968573 A1 EP2968573 A1 EP 2968573A1 EP 14714047 A EP14714047 A EP 14714047A EP 2968573 A1 EP2968573 A1 EP 2968573A1
Authority
EP
European Patent Office
Prior art keywords
weight
liquid composition
composition
liquid
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP14714047.9A
Other languages
English (en)
French (fr)
Inventor
Mahesh Sudhakar BHARATI
Houphouet Hyacinthe YARABE
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GSK Consumer Healthcare SARL
Novartis Consumer Health Inc
Original Assignee
Novartis Healthcare Pvt Ltd
Novartis Consumer Health Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Healthcare Pvt Ltd, Novartis Consumer Health Inc filed Critical Novartis Healthcare Pvt Ltd
Priority claimed from PCT/US2014/021590 external-priority patent/WO2014149939A1/en
Publication of EP2968573A1 publication Critical patent/EP2968573A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
EP14714047.9A 2013-03-15 2014-03-07 Farbstofffreie flüssige therapeutische lösung Withdrawn EP2968573A1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN765DE2013 2013-03-15
PCT/US2014/021590 WO2014149939A1 (en) 2013-03-15 2014-03-07 Dye free liquid therapeutic solution

Publications (1)

Publication Number Publication Date
EP2968573A1 true EP2968573A1 (de) 2016-01-20

Family

ID=54258944

Family Applications (1)

Application Number Title Priority Date Filing Date
EP14714047.9A Withdrawn EP2968573A1 (de) 2013-03-15 2014-03-07 Farbstofffreie flüssige therapeutische lösung

Country Status (4)

Country Link
EP (1) EP2968573A1 (de)
CN (1) CN105263524A (de)
CA (1) CA2906389A1 (de)
SG (1) SG11201507369WA (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110115708A (zh) * 2018-02-07 2019-08-13 保瑞药业股份有限公司 乙酰胺酚及曲马多共溶复方止痛口服液

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0714872B2 (ja) * 1990-02-06 1995-02-22 昭和薬品化工株式会社 シロップ剤組成物
US5505961A (en) * 1993-08-05 1996-04-09 R. P. Scherer Corporation Gelatin capsules containing a highly concentrated acetaminophen solution
US5616621A (en) * 1995-01-30 1997-04-01 American Home Products Corporation Taste masking liquids
IL161500A0 (en) * 2001-10-22 2004-09-27 Taro Pharma Ind Taste masking spill-resistant formulation
US20080085892A1 (en) * 2006-08-31 2008-04-10 Sangeetha Kandeepan Liquid dosage form of acetaminophen

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
None *
See also references of WO2014149939A1 *

Also Published As

Publication number Publication date
CN105263524A (zh) 2016-01-20
SG11201507369WA (en) 2015-10-29
CA2906389A1 (en) 2014-09-25

Similar Documents

Publication Publication Date Title
CA2333528C (en) A stabilized antihistamine syrup containing aminopolycarboxylic acid as stabilizer
TW201105334A (en) Topical formulation containing a tetracycline and a method of treating skin infections using the same
CA2567075A1 (en) Pharmaceutical suspension composition
JP2006312651A (ja) オキシカルバゼピン含有懸濁剤
WO2014149939A1 (en) Dye free liquid therapeutic solution
WO2014013903A1 (ja) タキサン系活性成分含有液体組成物、その製造方法及び液体製剤
JP4959335B2 (ja) メチルフェニデート溶液および関連する投与および製造方法
EP2968573A1 (de) Farbstofffreie flüssige therapeutische lösung
US20210322345A1 (en) Midodrine hydrochloride oral solution and uses thereof
JP5211677B2 (ja) 内服液剤
JPH0536412B2 (de)
US20040116528A1 (en) Ketoprofen compositons and methods of making them
US20210213024A1 (en) Liquid compositions of aprepitant
WO2024062443A1 (en) Pharmaceutical compositions
AU2004203644B2 (en) Pharmaceutical compositions
CN114828829A (zh) 包含布洛芬和去氧肾上腺素的液体组合物
WO2005034910A1 (en) Oral liquid pharmaceutical compositions of sertraline
MXPA00005129A (en) Liquid and stable antihistaminic - anti-congestive pharmaceutical compositions
ITMI991780A1 (it) Composizioni liquide orali contenenti citalopram

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20151013

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAX Request for extension of the european patent (deleted)
RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: NOVARTIS CONSUMER HEALTH, INC.

Owner name: NOVARTIS CONSUMER HEALTH S.A.

17Q First examination report despatched

Effective date: 20170220

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20171110